MedCap AB (publ)
STO:MCAP
Balance Sheet
Balance Sheet Decomposition
MedCap AB (publ)
MedCap AB (publ)
Balance Sheet
MedCap AB (publ)
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
61
|
15
|
21
|
147
|
140
|
236
|
188
|
370
|
370
|
|
| Cash Equivalents |
61
|
15
|
21
|
147
|
140
|
236
|
188
|
370
|
370
|
|
| Total Receivables |
138
|
114
|
132
|
124
|
166
|
199
|
275
|
239
|
350
|
|
| Accounts Receivables |
130
|
103
|
124
|
112
|
144
|
184
|
251
|
213
|
327
|
|
| Other Receivables |
7
|
11
|
8
|
12
|
22
|
16
|
25
|
26
|
23
|
|
| Inventory |
123
|
114
|
114
|
138
|
150
|
163
|
277
|
269
|
271
|
|
| Other Current Assets |
16
|
10
|
15
|
19
|
19
|
144
|
25
|
39
|
0
|
|
| Total Current Assets |
337
|
254
|
281
|
427
|
475
|
742
|
765
|
917
|
991
|
|
| PP&E Net |
48
|
55
|
204
|
193
|
254
|
243
|
244
|
403
|
379
|
|
| PP&E Gross |
48
|
55
|
204
|
193
|
254
|
243
|
244
|
403
|
0
|
|
| Accumulated Depreciation |
73
|
85
|
108
|
170
|
188
|
238
|
300
|
323
|
0
|
|
| Intangible Assets |
115
|
175
|
192
|
218
|
208
|
199
|
309
|
305
|
566
|
|
| Goodwill |
97
|
137
|
161
|
241
|
230
|
243
|
340
|
362
|
663
|
|
| Long-Term Investments |
1
|
1
|
2
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Other Long-Term Assets |
3
|
5
|
3
|
3
|
3
|
3
|
4
|
4
|
5
|
|
| Other Assets |
97
|
137
|
161
|
241
|
230
|
243
|
340
|
362
|
663
|
|
| Total Assets |
600
N/A
|
627
+4%
|
842
+34%
|
1 081
+28%
|
1 170
+8%
|
1 429
+22%
|
1 662
+16%
|
1 991
+20%
|
2 606
+31%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
70
|
75
|
52
|
55
|
50
|
76
|
91
|
73
|
351
|
|
| Accrued Liabilities |
33
|
32
|
48
|
39
|
53
|
64
|
98
|
103
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
127
|
95
|
167
|
107
|
92
|
116
|
69
|
61
|
102
|
|
| Other Current Liabilities |
27
|
29
|
35
|
60
|
47
|
47
|
85
|
95
|
42
|
|
| Total Current Liabilities |
257
|
231
|
301
|
261
|
242
|
302
|
343
|
332
|
494
|
|
| Long-Term Debt |
49
|
65
|
158
|
157
|
165
|
224
|
192
|
297
|
381
|
|
| Deferred Income Tax |
13
|
30
|
31
|
37
|
38
|
39
|
67
|
62
|
113
|
|
| Minority Interest |
3
|
3
|
5
|
6
|
2
|
2
|
4
|
6
|
7
|
|
| Other Liabilities |
14
|
28
|
19
|
25
|
26
|
6
|
33
|
12
|
159
|
|
| Total Liabilities |
335
N/A
|
356
+6%
|
514
+45%
|
486
-6%
|
474
-2%
|
573
+21%
|
639
+12%
|
709
+11%
|
1 154
+63%
|
|
| Equity | ||||||||||
| Common Stock |
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
0
|
|
| Retained Earnings |
37
|
32
|
114
|
177
|
262
|
402
|
576
|
784
|
0
|
|
| Additional Paid In Capital |
232
|
238
|
210
|
431
|
428
|
428
|
428
|
464
|
0
|
|
| Other Equity |
10
|
4
|
1
|
18
|
0
|
20
|
13
|
28
|
1 452
|
|
| Total Equity |
265
N/A
|
271
+2%
|
328
+21%
|
596
+82%
|
696
+17%
|
856
+23%
|
1 023
+19%
|
1 282
+25%
|
1 452
+13%
|
|
| Total Liabilities & Equity |
600
N/A
|
627
+4%
|
842
+34%
|
1 081
+28%
|
1 170
+8%
|
1 429
+22%
|
1 662
+16%
|
1 991
+20%
|
2 606
+31%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
15
|
15
|
15
|
15
|
15
|
15
|
|